Free Trial
OTCMKTS:APLIF

Appili Therapeutics (APLIF) Stock Price, News & Analysis

Appili Therapeutics logo
$0.01 +0.00 (+16.22%)
As of 05/27/2025 12:19 PM Eastern

About Appili Therapeutics Stock (OTCMKTS:APLIF)

Key Stats

Today's Range
$0.0129
$0.0144
50-Day Range
$0.01
$0.03
52-Week Range
$0.01
$0.04
Volume
600 shs
Average Volume
91,037 shs
Market Capitalization
$1.56 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada. Its anti-infective portfolio includes ATI-1501, a taste-masked liquid oral suspension formulation of the antibiotic metronidazole to treat anaerobic bacterial, protozoal, and parasitic infections; ATI-1801, a novel topical formulation of paromomycin in Phase III clinical trials for the treatment of cutaneous leishmaniasis and disfiguring skin infections; and ATI-1701, which is a live-attenuated vaccine in preclinical trials for Francisella tularensis. The company was incorporated in 2015 and is headquartered in Halifax, Canada.

Receive APLIF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Appili Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

APLIF Stock News Headlines

AI Meltdown Imminent: Dump These Stocks Now!
If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.
See More Headlines

APLIF Stock Analysis - Frequently Asked Questions

Appili Therapeutics' stock was trading at $0.0280 at the beginning of 2025. Since then, APLIF stock has decreased by 53.9% and is now trading at $0.0129.
View the best growth stocks for 2025 here
.

Appili Therapeutics Inc. (OTCMKTS:APLIF) posted its earnings results on Tuesday, August, 13th. The company reported ($0.01) EPS for the quarter, hitting the consensus estimate of ($0.01).

Shares of APLIF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/13/2024
Today
5/28/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:APLIF
CIK
N/A
Fax
N/A
Employees
8
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$2.80 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$630,000.00
Price / Cash Flow
N/A
Book Value
($0.05) per share
Price / Book
-0.26

Miscellaneous

Free Float
106,908,000
Market Cap
$1.56 million
Optionable
Not Optionable
Beta
-0.51
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (OTCMKTS:APLIF) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners